AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Knoglina Nasal Spray

Prescription Icon
Prescription Required

Marketer

Progress Pharma Private Limited

Salt Composition

Calcitonin (Salmon) (200IU)

Overview Knoglina Nasal Spray

Nasal OsteoSpray is a medication prescribed to treat postmenopausal osteoporosis, enhancing bone density and reducing fracture risk. It may also alleviate bone pain related to Paget's disease. Administer OsteoSpray precisely as directed by your physician. Before each dose, gently clear your nasal passages. Apply the spray to one nostril, keeping the other closed, then inhale deeply to ensure proper distribution. Repeat for the other nostril. Concurrent calcium and vitamin D supplementation is recommended to optimize treatment efficacy. Common, typically mild, side effects include nasal discharge, epistaxis, backache, arthralgia, headache, and nasal irritation/discomfort. Persistent or bothersome side effects warrant medical attention. Prior to commencing treatment, inform your doctor of any pre-existing cardiac, renal, or hepatic conditions. Consult your doctor before using OsteoSpray if you are pregnant or breastfeeding.

Primary Ingredients of Knoglina Nasal Spray

No text provided. Please provide the text you wish to be rephrased.

Uses of Knoglina Nasal Spray

Osteoporosis and Paget's disease in postmenopausal women

Major Benefits of Knoglina Nasal Spray:

Follow your doctor's instructions or consult the product label for usage guidelines.

Common Side effects of Knoglina Nasal Spray:

  • Runny nose
  • Nosebleeds
  • Nasal irritation
  • Back pain
  • Joint pain
  • Headache

How to use Knoglina Nasal Spray:

Follow your doctor's instructions or consult the product label for usage guidance.

How Knoglina Nasal Spray works:

Calcitonin receptor stimulation is achieved with Knoglina Nasal Spray. This reduces osteoclast activity, the cells responsible for bone breakdown, leading to enhanced bone strength and a decreased fracture risk.

SAFETY ADVICE

AlcoholAlcoholNone

No known drug interactions.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Knoglina Nasal Spray during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Employing Knoglina Nasal Spray while breastfeeding is likely inadvisable. Scant evidence from human studies indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingNone

No known drug interactions.

KidneyKidneyNone

No drug interactions identified.

LiverLiverNone

No known drug interactions.

What if you forget to take Knoglina Nasal Spray :

Should you forget a dose of Knoglina Nasal Spray, administer it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Knoglina Nasal Spray

LabelValue
Chemical Category Endocrine Signals
Developing Habits No.
Treatment Category Pain Relievers

FAQs on Knoglina Nasal Spray

Knoglina Nasal Spray requires refrigeration before opening, ideally between 2°C and 8°C. Do not freeze. After opening, store at room temperature (15°C to 30°C).
Knoglina Nasal Spray uses calcitonin, a naturally occurring thyroid hormone, to regulate calcium balance. This helps reduce bone loss and damage in osteoporosis patients, and may even stimulate bone formation and increase bone density in some cases.
Knoglina Nasal Spray may lower blood calcium levels. Severely low blood calcium can cause numbness or tingling in the fingers, toes, or mouth. Blood calcium should be monitored; contact your doctor immediately if these symptoms occur.
Use this medication as directed by your doctor; ask if you have questions. Typically, one spray is administered in a single nostril daily. Begin with one spray in the left nostril on day one, then the right nostril on day two, alternating nostrils daily. Each bottle contains 30 doses. Discard the bottle after 30 days.
Pregnancy and Knoglina Nasal Spray use are not generally recommended. Insufficient evidence exists to confirm a link between the spray and birth defects or miscarriage, but caution is advised. Use during pregnancy should only occur if a doctor deems the potential benefits significantly outweigh the risks.
Knoglina Nasal Spray
1,806
MRP 2,200
17% off